???global.info.a_carregar???
Luis Carvalho completed the Master's Degree in Pharmaceutical Sciencies in 2013 in the Faculty of Pharmacy of the University of Lisbon. During this period, Luis received a research initiation grant from the University of Lisbon and Fundação Amadeu Dias in 2010. After this grant, Luis enroled in Rui Moreira's lab in 2011 as an undergraduate student to contact with Organic Chemistry Synthesis and develop enzymatic inhibitors for Human Neutrophil Elastase. Luis enrolled in an FCT-funded PhD with Rui Moreira's lab in the Medicinal Chemistry group of the Research Institute for Medicines of the University of Lisbon, in collaboration with Instituto Nacional de Saúde Dr. Ricardo Jorge, in the field of Medicinal Chemistry, working in the derivatization of small molecule enzymatic inhibitors as probes for diagnostic purposes. During his PhD, Luis received a Fulbright grant to work at the Cravatt Lab in The Scripps Research Institute in California, where he was trained in Activity-based Protein Profiling and Proteomics. During his PhD Luis co-organized two editions of the Postgraduate iMed.ULisboa Students Meeting, participated as a representative of iMed.ULisboa in the European Researcher's Night and worked as a volunteer with Scripps Assists of The Scripps Research Institute in the Lagoon Project, which aimed at the maintenance of the Torrey Pines Natural Reserve and local event organization. Luis completed his Phd in 2020 and readily enrolled in Post-doctoral research with the Bernardes Group at Instituto de Medicina Molecular, where he developed serine hydrolase targeting PROTACs and innovative proteomics platforms that took advantage of the extensive repertoire of the group in covalent chemical binders. In 2021 Luis received a Marie Curie Individual Fellowship to join the Bernardes Lab in the Yusuf Hamied Department of Chemistry in the University of Cambridge. Luis is currently a Senior Laboratory Research Scientist at The Francis Crick Institute, working in the application of proteomics technologies in the discovery and study of molecular glues.
Identificação

Identificação pessoal

Nome completo
Luis Miguel Afonso Ramos de Carvalho

Nomes de citação

  • Luis A. R. Carvalho

Identificadores de autor

Ciência ID
4410-D3B9-BA75
ORCID iD
0000-0001-5257-7301

Moradas

  • The Francis Crick Institute, 1 Midland Road, NW1 1AT, London, London, Reino Unido (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Química Médica
  • Ciências Médicas e da Saúde - Medicina Básica - Química Médica
  • Ciências Exatas - Química - Química Orgânica
  • Ciências Médicas e da Saúde - Outras Ciências Médicas

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português (Idioma materno)
Formação
Grau Classificação
2021/10/01 - 2023/09/30
Em curso
Marie Curie Postdoctoral Researcher (Pós-doutoramento)
University of Cambridge Department of Chemistry, Reino Unido
2020/04/06 - 2021/09/30
Concluído
Post-doctoral Researcher (Pós-doutoramento)
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2015/03/01 - 2020/02/10
Concluído
Doutoramento em Farmácia - Especialidade Química Farmacêutica e Terapêutica (Doutoramento)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
"3-Oxo-ß-Sultams and 4-Oxo-ß-Lactams as Chemical Tools for Activity-based Protein Profiling of Serine Hydrolases" (TESE/DISSERTAÇÃO)
Aprovado com Louvor e Distinção
2013
Concluído
Mestrado Integrado em Ciências Farmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Monografia: Activity-Based Probes for the study of Proteases" (TESE/DISSERTAÇÃO)
17 Valores
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2024/06/17 - Atual Investigador Contratado (Investigação) The Francis Crick Institute, Reino Unido
The Francis Crick Institute, Reino Unido
2021/10/01 - Atual Pós-doutorado (Investigação) University of Cambridge Department of Chemistry, Reino Unido
University of Cambridge Department of Chemistry, Reino Unido
2020/04/06 - 2021/09/30 Pós-doutorado (Investigação) Instituto de Medicina Molecular João Lobo Antunes, Portugal
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2017/09/13 - 2018/07/09 Investigador visitante (Investigação) Scripps Research Institute, Estados Unidos
Scripps Research Institute, Estados Unidos
(...)

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2015/03/01 - 2020/02/10 PhD Student Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2014/06/17 - 2014/10/17 Scientific Research in the Toxicology field. (MERTOX-TRX) Molecular Mechanisms of Mercury Toxicicty: Study of the inhibition of the thioredoxin system in the human population. (PTDC/QUI-BIQ/117281) Universidade de Lisboa Faculdade de Farmácia, Portugal
2013/09/02 - 2013/10/31 Internship in Hospital Pharmacy, part of Pharmaceutical Sciences Master's Degree Hospital CUF Descobertas, Portugal
2013/03/01 - 2013/06/28 Internship in Community Pharmacy, part of Pharmaceutical Sciences Master's Degree Farmácia Comunitária do Hospital Santa Maria, Portugal
2010/12/23 - 2012/12/22 Monitor in supervision of Master's Degree classes: Organic Chemistry and Chemistry Physics. Contract with the Faculty of Pharmacy of the University of Lisbon. Universidade de Lisboa Faculdade de Farmácia, Portugal
2010/12/23 - 2012/11/30 Scientific Research in Medicinal Chemistry - Rui Moreira's Grouop - Synthesis of Elastase Inhibitors Universidade de Lisboa Faculdade de Farmácia, Portugal
2010/09/30 - 2011/10/12 Universidade de Lisboa - Fundação Amadeu Dias Grant 2010/2011 Project: "Analysis of the Release Profile of Levofloxacin from Calcium Phosphate Microparticles". Universidade de Lisboa, Portugal
Projetos

Bolsa

Designação Financiadores
2015/03/01 - 2020/02/10 ActiProbe: Actvity-based Probes as Chemical Tools for Biomarker Discovery in Chronic Obstructive Pulmonary Disease
SFRH/BD/100400/2014
Bolseiro de Doutoramento
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Fundação para a Ciência e a Tecnologia
Concluído

Projeto

Designação Financiadores
2024/06/14 - Atual UKRI Prosperity Partnership - Rule book for molecular glue degraders
EP/X025357/1
Investigador
The Francis Crick Institute, Reino Unido
Engineering and Physical Sciences Research Council

AstraZeneca Diagnostics
Em curso
2021/10/01 - 2023/09/30 ABPP-PROTDRUG - An Activity-based Protein An Activity-based Protein Profiling-supported Protein Therapeutic Drug development platform for the development of innovative anti-cancer therapies based on Lin28 inhibition
101022421
Investigador Pós-doutorado
University of Cambridge Department of Chemistry, Reino Unido
Horizon 2020
Em curso
2020/04/06 - 2021/09/30 Intracellular Drug Delivery using Small Molecule Drug Conjugates for Prostate Cancer Therapy
IMM/CT/3-2020
Bolseiro de Pós-Doutoramento
Instituto de Medicina Molecular João Lobo Antunes, Portugal
Concluído

Outro

Designação Financiadores
2015/03/01 - 2019/03/15 ProbeCOPD. Protease activity-based probes for Chronic Obstructive Pulmonary Disease diagnostics
PTDC/BBB-BEP/2463/2014
Bolseiro de Doutoramento
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Concluído
2014/07 - 2014/10 (MERTOX-TRX) Molecular Mechanisms of Mercury Toxicity: Study of the inhibition of human thioredoxin system
Bolseiro de Mestrado
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Concluído
Produções

Publicações

Artigo em revista
  1. Carvalho, Luís A. R.; Sousa, Bárbara B.; Zaidman, Daniel; Kiely-Collins, Hannah; Bernardes, Gonçalo J. L.. "Design and Evaluation of PROTACs Targeting Acyl Protein Thioesterase 1". ChemBioChem 25 4 (2024): https://doi.org/10.1002/cbic.202300736.
    10.1002/cbic.202300736
  2. Branco, Vasco; Carvalho, Luís; Barboza, Cássia; Mendes, Eduarda; Cavaco, Afonso; Carvalho, Cristina. "Selenium and Redox Enzyme Activity in Pregnant Women Exposed to Methylmercury". Antioxidants 11 11 (2022): 2291. http://dx.doi.org/10.3390/antiox11112291.
    Acesso aberto • Publicado • 10.3390/antiox11112291
  3. Sousa, Bárbara B.; de Almeida, Cátia Rebelo; Barahona, Ana F.; Lopes, Raquel; Martins-Logrado, Ana; Cavaco, Marco; Neves, Vera; et al. "Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors". ACS Pharmacology & Translational Science 5 11 (2022): 1156-1168. http://dx.doi.org/10.1021/acsptsci.2c00163.
    10.1021/acsptsci.2c00163
  4. Carvalho, Luís A. R.; Ross, Breyan; Fehr, Lorenz; Bolgi, Oguz; Wöhrle, Svenja; Lum, Kenneth M.; Podlesainski, David; et al. "Chemoproteomics-Enabled Identification of 4-Oxo-ß-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9". Angewandte Chemie International Edition 61 47 (2022): http://dx.doi.org/10.1002/anie.202210498.
    Acesso aberto • Publicado • 10.1002/anie.202210498
  5. Carvalho, Luís A. R.; Ross, Breyan; Fehr, Lorenz; Bolgi, Oguz; Wöhrle, Svenja; Lum, Kenneth M.; Podlesainski, David; et al. "Chemoproteomik-basierte Identifikation von 4-Oxo-ß-lactamen als Inhibitoren der Dipeptidylpeptidasen 8¿und 9". Angewandte Chemie 134 47 (2022): http://dx.doi.org/10.1002/ange.202210498.
    Acesso aberto • Publicado • 10.1002/ange.202210498
  6. Carvalho, Luís A. R.; Bernardes, Gonçalo J. L.. "The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery". ChemMedChem 17 14 (2022): http://dx.doi.org/10.1002/cmdc.202200174.
    Acesso aberto • Publicado • 10.1002/cmdc.202200174
  7. Barbosa, Marta; Gomes, Cátia; Sequeira, Catarina; Gonçalves-Ribeiro, Joana; Pina, Carolina Campos; Carvalho, Luís A.; Moreira, Rui; et al. "Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons". Frontiers in Cell and Developmental Biology 9 (2021): http://dx.doi.org/10.3389/fcell.2021.634355.
    10.3389/fcell.2021.634355
  8. Carvalho, Luís A. R.; Almeida, Vanessa T.; Brito, José A.; Lum, Kenneth M.; Oliveira, Tânia F.; Guedes, Rita C.; Gonçalves, Lídia M.; et al. "3-Oxo-ß-sultam as a Sulfonylating Chemotype for Inhibition of Serine Hydrolases and Activity-Based Protein Profiling". ACS Chemical Biology 15 4 (2020): 878-883. http://dx.doi.org/10.1021/acschembio.0c00090.
    Publicado • 10.1021/acschembio.0c00090
  9. Vaz, Ana Rita; Pinto, Sara; Ezequiel, Catarina; Cunha, Carolina; Carvalho, Luís A.; Moreira, Rui; Brites, Dora. "Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions". Frontiers in Cellular Neuroscience 13 (2019): http://dx.doi.org/10.3389/fncel.2019.00109.
    10.3389/fncel.2019.00109
  10. Falcão, Ana S.; Carvalho, Luís A. R.; Lidónio, Gonçalo; Vaz, Ana R.; Lucas, Susana D.; Moreira, Rui; Brites, Dora. "Dipeptidyl Vinyl Sulfone as a Novel Chemical Tool to Inhibit HMGB1/NLRP3-Inflammasome and Inflamma-miRs in Aß-Mediated Microglial Inflammation". ACS Chemical Neuroscience 8 1 (2016): 89-99. http://dx.doi.org/10.1021/acschemneuro.6b00250.
    10.1021/acschemneuro.6b00250
  11. Ruivo, Eduardo F. P.; Gonçalves, Lídia M.; Carvalho, Luís A. R.; Guedes, Rita C.; Hofbauer, Stefan; Brito, José A.; Archer, Margarida; Moreira, Rui; Lucas, Susana D.. "Clickable 4-Oxo-ß-lactam-Based Selective Probing for Human Neutrophil Elastase Related Proteomes". ChemMedChem 11 18 (2016): 2037-2042. http://dx.doi.org/10.1002/cmdc.201600258.
    10.1002/cmdc.201600258
  12. Carvalho, L. A. R.; Ruivo, E. F. P.; Lucas, S. D.; Moreira, R.. "Activity-based probes as molecular tools for biomarker discovery". MedChemComm 6 4 (2015): 536-546. http://dx.doi.org/10.1039/c4md00417e.
    10.1039/c4md00417e
  13. Lucas, Susana D.; Gonçalves, Lídia M.; Carvalho, Luís A. R.; Correia, Henrique F.; Da Costa, Eduardo M. R.; Guedes, Romina A.; Moreira, Rui; Guedes, Rita C.. "Optimization of O3-Acyl Kojic Acid Derivatives as Potent and Selective Human Neutrophil Elastase Inhibitors". Journal of Medicinal Chemistry 56 23 (2013): 9802-9806. http://dx.doi.org/10.1021/jm4011725.
    10.1021/jm4011725
Poster em conferência
  1. Luis A. R. Carvalho. "Rational Design of PROTAC Linkers using the PRosettaC Software". Trabalho apresentado em SIMICA Summer School - Therapeutic Site-selective Protein-modification Chemistries, 2022.
  2. Luis A. R. Carvalho; K. M. Lum; B. Ross; S. D. Lucas; R. Huber; B. F. Cravatt; R. Moreira. "Activity-based Protein Profiling using 4-Oxo-ß-Lactams uncovers a new Chemotype for DPP8 and DPP9 Inhibition". Trabalho apresentado em 11th iMed.ULisboa Postgraduate Students Meeting & 4nd i3DU Meeting, 2019.
  3. Luis A. R. Carvalho; L. M. Gonçalves; F. Vaz; S. D. Lucas; D. Penque; R. Moreira. "A Chemoproteomic approach to validate Human Neutrophil Elastase as a Biomarker of Chronic Obstructive Pulmonary Disease". Trabalho apresentado em 1º Encontro – A Química na Investigação da ULisboa, 2017.
  4. Luis A. R. Carvalho; L. M. Gonçalves; F. Vaz; S. D. Lucas; D. Penque; R. Moreira. "A Chemoproteomic approach to validate Human Neutrophil Elastase as a Biomarker of Chronic Obstructive Pulmonary Disease". Trabalho apresentado em XXV Encontro Nacional da SPQ, 2017.
  5. Luis A. R. Carvalho; L. M. Gonçalves; F. Vaz; S. D. Lucas; D. Penque; R. Moreira. "A Chemoproteomic approach to validate Human Neutrophil Elastase as a Biomarker of Chronic Obstructive Pulmonary Disease". Trabalho apresentado em 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  6. Luis A. R. Carvalho; R. Moreira; S. D. Lucas. "ACTIPROBE: Activity-based probes as chemical tools for biomarker discovery in chronic obstructive pulmonary disease". Trabalho apresentado em 5th Portuguese Young Chemists Meeting, 1st European Young Chemists Meeting, 2016.
  7. Luis A. R. Carvalho; R. Moreira; S. D. Lucas. "ACTIPROBE: Activity-based probes as chemical tools for biomarker discovery in chronic obstructive pulmonary disease". Trabalho apresentado em 11th National Encounter of Organic Chemistry, 4º National Encounter of Therapeutic Chemistry, 2015.
Tese / Dissertação
  1. Luis A. R. Carvalho. "3-Oxo-ß-Sultams and 4-Oxo-ß-Lactams as Chemical Tools for Activity-based Protein Profiling of Serine Hydrolases". Doutoramento, Universidade de Lisboa Instituto de Investigação do Medicamento, 2020.

Outros

Outra produção
  1. Cover Picture: Chemoproteomics-Enabled Identification of 4-Oxo-ß-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9 (Angew. Chem. Int. Ed. 47/2022). Front cover picture of Angewandte Chemie (Angew. Chem. Int. Ed. 47/2022). Designed by Luis A. R. Carvalho (Self). 2022. Luis A. R. Carvalho. https://onlinelibrary.wiley.com/doi/full/10.1002/anie.202213804.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2025/01/13 MS Imaging and Spatial Proteomics 3rd ISOBIOTICS Training Event
GIMM (Lisbon, Portugal)
2022/09/01 Proteomics Solutions in Chemical Biology: 4-Oxo-ß-Lactams as Chemical Tools for Activity-based Protein Profiling of Serine Hydrolases & Rational Design of PROTAC Linkers 2nd Young Investigator Workshop 2022
EuChemS - Division of Chemistry in Life Sciences (Lisbon, Portugal)
2021/10/13 Serine Hydrolase PROTACs & Proteomics Solutions in Chemical Biology Chemical Biology of Carbon Monoxide Symposium
ACORN Project - A Nanoparticle-based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules (Algarve, Portugal)
2019/03/29 Activity-based Protein Profiling of Serine Hydrolases using 4-Oxo-ß-Lactams ABPP Symposium 2019 – Target Discovery and Visualization using Chemical Probes
University of Leuven (Leuven, Bélgica)
2017/07/06 Activity-Based Probes as Chemical Tools for Biomarker Discovery in Chronic Obstructive Pulmonary Disease European School of Medicinal Chemistry ESMEC
University of Urbino (Urbino, Itália)
2017/05/19 Activity-Based Probes as Chemical Tools for Biomarker Discovery in Chronic Obstructive Pulmonary Disease IV SEQT Symposium of Medicinal Chemistry Young Researchers
University of Barcelona (Barcelona, Espanha)
2017/05/08 Activity-Based Probes as Chemical Tools for Biomarker Discovery in Chronic Obstructive Pulmonary Disease by a Proteomics-Based Approach Young Investigator Day at Instituto Nacional de Saúde Dr. Ricardo Jorge
Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisbon, Portugal)
2015/07/15 Acti-Probe: Activity-based probes as chemical tools for biomarker discovery in Chronic Obstructive Pulmonary Disease 7th iMed.ULisboa Postgraduate Students Meeting
Research Institute for Medicines (iMed.ULisboa) (Lisbon, Portugal)
2015/04/09 Blood and Plasma concentrations of Selenium in the Portuguese Population Selenium and Selenoproteins in Health and Disease
Research Institute for Medicines (iMed.ULisboa)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação)
Instituição / Organização
2016 - 2017 Member of the organizing committee (ipSC – Postgraduate Students’ Association) of the 8th edition of the Postgraduate iMed.ULisboa Students Meeting (2016)
Encontro (Membro da Comissão Organizadora)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2015 - 2016 Member of the organizing committee (ipSC – Postgraduate Students’ Association) of the 7th edition of the Postgraduate iMed.ULisboa Students Meeting (2015)
Encontro (Membro da Comissão Organizadora)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Participação em evento

Descrição da atividade
Tipo de evento
Nome do evento
Instituição / Organização
2015 - Atual European Researcher’s Night – As a member of the ipSC of iMed.ULisboa, organization and participation in the activity Gelify yourself! with the preparation of carbopol gels, showcasing pharmaceutical formula development to the public. European Researcher’s Night
2020/10/19 - 2020/10/22 Summer School and Thematic Workshop
Encontro
Acorn - Nanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules - Summer School and Thematic Workshop
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2017/09 - 2018/07 Volunteer with Scripps Assists from The Scripps Research Institute at the Lagoon Project in San Diego, California. Activities included maintenance of the Torrey Pines Natural Reserve and local event organization at the reserve as part of the participation in the Fulbright program.
Outro
Scripps Research Institute, Estados Unidos

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2022/05/31 - Atual Activity-based Protein Profiling (ABPP) 3-Oxo-ß-Sultams and 4-Oxo-ß-Lactams as Chemical Tools for Activity-based Protein Profiling of Serine Hydrolases - Invited Lecturer Medicinal and Biopharmaceutical Chemistry (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
Distinções

Prémio

2015 Winner of the 'Why Medicinal Chemistry?' Videoclip Competition
The European Federation for Medicinal Chemistry (EFMC), Bélgica
2015 Best Oral Presentation by a Young Investigator at the conference Selenium and Selenoproteins in Health and Disease sponsored by Santa Cruz Biotechnology.
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Outra distinção

2022 Article 'Chemoproteomics-Enabled Identification of 4-Oxo-ß-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9' highlighted as a 'Hot Paper' in Angewandte Chemie Volume 61, Issue 47
2022 Article 'Chemoproteomics-Enabled Identification of 4-Oxo-ß-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9' featured on the main cover of Angewandte Chemie Volume 61, Issue 47.
2020 Marie Curie Individual Fellowship, H2020-MSCA-IF-2020 call for research in The University of Cambridge, UK.
Horizon 2020, Bélgica
2017 FCT-supported Fulbright Grant
Fulbright Portugal, Portugal
2017 Grant to attend the European School of Medicinal Chemistry ESMEC in Urbino, July 2nd-6th, 2017.
The European Federation for Medicinal Chemistry (EFMC), Bélgica
2015 Best Oral Presentation by a Young Investigator at the conference 'Selenium and Selenoproteins in Health and Disease'.
2014 JmedChem article 'Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors' featured by Global Medical Discovery as key drug discovery article.
2013 Prémio Escolar de Incentivo à Formação Pós-Graduada da Faculdade de Farmácia da Universidade de Lisboa, 3º Prémio - Ano Lectivo 2012/2013
Universidade de Lisboa Faculdade de Farmácia, Portugal
2010 Universidade de Lisboa/ Fundação Amadeu Dias Grant